Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy
- 31 January 1997
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer
- Vol. 33 (1), 75-79
- https://doi.org/10.1016/s0959-8049(96)00309-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Low dose megestrol acetate can abrogate cachexia in advanced tumor patients receiving systemic interferon-α and/or interleukin-2 based antineoplastic therapyAnti-Cancer Drugs, 1993
- Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutionsEuropean Journal of Cancer, 1992
- Progress, problems and priorities in quality of life researchEuropean Journal of Cancer, 1992
- Percutaneous Endoscopically Guided Gastrostomy in Patients with Head and Neck CancerRecent Results in Cancer Research, 1991
- A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancerCancer, 1990
- Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and CachexiaJNCI Journal of the National Cancer Institute, 1990
- The effect of oral nutritional supplements on head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Malnutrition and the Role of Nutritional Support for Radiation Therapy PatientsRecent Results in Cancer Research, 1988
- High-dose megestrol acetate. A possible treatment for cachexiaJAMA, 1987
- Quality of Life Index for Patients with CancerResearch in Nursing & Health, 1983